
Nancy J. Leith
Examiner (ID: 12198, Phone: (313)446-4874 , Office: P/1636 )
| Most Active Art Unit | 1636 |
| Art Unit(s) | 1636, 1811, 1815, 1941, 1805 |
| Total Applications | 1445 |
| Issued Applications | 999 |
| Pending Applications | 194 |
| Abandoned Applications | 284 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14072315
[patent_doc_number] => 20190085045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => METHODS OF PRODUCING TWO CHAIN PROTEINS IN BACTERIA
[patent_app_type] => utility
[patent_app_number] => 16/045517
[patent_app_country] => US
[patent_app_date] => 2018-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40721
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16045517
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/045517 | Methods of producing two chain proteins in bacteria | Jul 24, 2018 | Issued |
Array
(
[id] => 17351708
[patent_doc_number] => 11226339
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-18
[patent_title] => Methods for high throughput receptor:ligand identification
[patent_app_type] => utility
[patent_app_number] => 16/044608
[patent_app_country] => US
[patent_app_date] => 2018-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 49
[patent_no_of_words] => 19724
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16044608
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/044608 | Methods for high throughput receptor:ligand identification | Jul 24, 2018 | Issued |
Array
(
[id] => 17228952
[patent_doc_number] => 20210355508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => Method for Modulating RNA Splicing by Inducing Base Mutation at Splice Site or Base Substitution in Polypyrimidine Region
[patent_app_type] => utility
[patent_app_number] => 16/982017
[patent_app_country] => US
[patent_app_date] => 2018-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16923
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16982017
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/982017 | Method for Modulating RNA Splicing by Inducing Base Mutation at Splice Site or Base Substitution in Polypyrimidine Region | Jul 23, 2018 | Pending |
Array
(
[id] => 13552509
[patent_doc_number] => 20180327802
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => SEPARATOME-BASED PROTEIN EXPRESSION AND PURIFICATION PLATFORM
[patent_app_type] => utility
[patent_app_number] => 16/040000
[patent_app_country] => US
[patent_app_date] => 2018-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24103
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 256
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16040000
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/040000 | SEPARATOME-BASED PROTEIN EXPRESSION AND PURIFICATION PLATFORM | Jul 18, 2018 | Abandoned |
Array
(
[id] => 14261701
[patent_doc_number] => 10280403
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-07
[patent_title] => Host cells with artificial endosymbionts
[patent_app_type] => utility
[patent_app_number] => 16/033679
[patent_app_country] => US
[patent_app_date] => 2018-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7752
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16033679
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/033679 | Host cells with artificial endosymbionts | Jul 11, 2018 | Issued |
Array
(
[id] => 17421506
[patent_doc_number] => 11254951
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-22
[patent_title] => Artificial nucleic acid molecules
[patent_app_type] => utility
[patent_app_number] => 16/030018
[patent_app_country] => US
[patent_app_date] => 2018-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 39401
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16030018
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/030018 | Artificial nucleic acid molecules | Jul 8, 2018 | Issued |
Array
(
[id] => 20226360
[patent_doc_number] => 12415000
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-16
[patent_title] => CRISPR system based antiviral therapy
[patent_app_type] => utility
[patent_app_number] => 16/629310
[patent_app_country] => US
[patent_app_date] => 2018-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 14
[patent_no_of_words] => 80674
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16629310
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/629310 | CRISPR system based antiviral therapy | Jul 5, 2018 | Issued |
Array
(
[id] => 13793955
[patent_doc_number] => 20190010516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-10
[patent_title] => METHOD AND SYSTEM FOR INCORPORATION OF BIOMOLECULES INTO VESICLES, CELLS, AND MICELLES USING ELECTROACTIVE POROUS DEVICE MEMBRANE
[patent_app_type] => utility
[patent_app_number] => 16/026709
[patent_app_country] => US
[patent_app_date] => 2018-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8675
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16026709
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/026709 | Method and system for incorporation of biomolecules into vesicles, cells, and micelles using electroactive porous device membrane | Jul 2, 2018 | Issued |
Array
(
[id] => 16824597
[patent_doc_number] => 20210139890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => NOVEL CRISPR RNA TARGETING ENZYMES AND SYSTEMS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/626932
[patent_app_country] => US
[patent_app_date] => 2018-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48416
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -78
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16626932
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/626932 | NOVEL CRISPR RNA TARGETING ENZYMES AND SYSTEMS AND USES THEREOF | Jul 1, 2018 | Pending |
Array
(
[id] => 14407643
[patent_doc_number] => 20190169665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => Gene Synthesis by Self-Assembly of Small Oligonucleotide Building Blocks
[patent_app_type] => utility
[patent_app_number] => 16/023960
[patent_app_country] => US
[patent_app_date] => 2018-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5770
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16023960
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/023960 | Gene Synthesis by Self-Assembly of Small Oligonucleotide Building Blocks | Jun 28, 2018 | Abandoned |
Array
(
[id] => 13871423
[patent_doc_number] => 20190032052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => METHODS, SYSTEMS, AND APPARATUS FOR IDENTIFYING TARGET SEQUENCES FOR CAS ENZYMES OR CRISPR-CAS SYSTEMS FOR TARGET SEQUENCES AND CONVEYING RESULTS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/012692
[patent_app_country] => US
[patent_app_date] => 2018-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41652
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16012692
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/012692 | METHODS, SYSTEMS, AND APPARATUS FOR IDENTIFYING TARGET SEQUENCES FOR CAS ENZYMES OR CRISPR-CAS SYSTEMS FOR TARGET SEQUENCES AND CONVEYING RESULTS THEREOF | Jun 18, 2018 | Abandoned |
Array
(
[id] => 13521985
[patent_doc_number] => 20180312535
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => PHOSPHATE REPLACEMENT MRNA CAP ANALOGS
[patent_app_type] => utility
[patent_app_number] => 16/008655
[patent_app_country] => US
[patent_app_date] => 2018-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46692
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16008655
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/008655 | Phosphate replacement mRNA cap analogs | Jun 13, 2018 | Issued |
Array
(
[id] => 13841415
[patent_doc_number] => 20190024192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-24
[patent_title] => ENGINEERED GENETIC ENTERIC SENSOR BACTERIA AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/000185
[patent_app_country] => US
[patent_app_date] => 2018-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26688
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16000185
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/000185 | Engineered genetic enteric sensor bacteria and uses thereof | Jun 4, 2018 | Issued |
Array
(
[id] => 13522601
[patent_doc_number] => 20180312843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => STAT3 INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/984086
[patent_app_country] => US
[patent_app_date] => 2018-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54439
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15984086
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/984086 | STAT3 inhibitors and uses thereof | May 17, 2018 | Issued |
Array
(
[id] => 15524747
[patent_doc_number] => 20200054679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-20
[patent_title] => Compositions and Methods for Gene Editing in T cells using CRISPR/Cpf1
[patent_app_type] => utility
[patent_app_number] => 16/609628
[patent_app_country] => US
[patent_app_date] => 2018-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16010
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16609628
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/609628 | Compositions and methods for gene editing in T cells using CRISPR/Cpf1 | May 1, 2018 | Issued |
Array
(
[id] => 13827147
[patent_doc_number] => 20190017058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-17
[patent_title] => CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION
[patent_app_type] => utility
[patent_app_number] => 15/967495
[patent_app_country] => US
[patent_app_date] => 2018-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52727
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15967495
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/967495 | CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION | Apr 29, 2018 | Pending |
Array
(
[id] => 17621184
[patent_doc_number] => 11340232
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-24
[patent_title] => Peptide constructs and assay systems
[patent_app_type] => utility
[patent_app_number] => 15/967461
[patent_app_country] => US
[patent_app_date] => 2018-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 19
[patent_no_of_words] => 21310
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 209
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15967461
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/967461 | Peptide constructs and assay systems | Apr 29, 2018 | Issued |
Array
(
[id] => 13902389
[patent_doc_number] => 20190040399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION
[patent_app_type] => utility
[patent_app_number] => 15/967510
[patent_app_country] => US
[patent_app_date] => 2018-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52273
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15967510
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/967510 | CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION | Apr 29, 2018 | Abandoned |
Array
(
[id] => 13607651
[patent_doc_number] => 20180355375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-13
[patent_title] => CRISPR-Cas Nickase Systems, Methods And Compositions For Sequence Manipulation in Eukaryotes
[patent_app_type] => utility
[patent_app_number] => 15/967464
[patent_app_country] => US
[patent_app_date] => 2018-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49427
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15967464
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/967464 | CRISPR-Cas Nickase Systems, Methods And Compositions For Sequence Manipulation in Eukaryotes | Apr 29, 2018 | Pending |
Array
(
[id] => 14072873
[patent_doc_number] => 20190085324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => ASSAYS FOR MASSIVELY COMBINATORIAL PERTURBATION PROFILING AND CELLULAR CIRCUIT RECONSTRUCTION
[patent_app_type] => utility
[patent_app_number] => 15/965192
[patent_app_country] => US
[patent_app_date] => 2018-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 115197
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15965192
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/965192 | Assays for massively combinatorial perturbation profiling and cellular circuit reconstruction | Apr 26, 2018 | Issued |